Government gives nod to commercial export of Covishield and Covaxin in view of sufficient stock Read more
US FDA approves Takeda’s Livtencity to treat people with post-transplant Cytomegalovirus infection Read more
Covaxin shows 50 per cent effectiveness against symptomatic COVID in real-world assessment: Lancet study Read more
Alembic Pharmaceuticals announces US FDA tentative approval for Dabigatran Etexilate capsules Read more